Group One Trading
SLDB icon

Group One Trading’s Solid Biosciences SLDB Stock Holding History

Group One Trading’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.3K Buy
+4,230
New +$32.1K ﹤0.01% 5502
2026
Q1 		– Sell
-6,553
Closed -$42.1K – 8645
2025
Q4 		$37K Buy
6,553
+1,803
+38% +$9.77K ﹤0.01% 5846
2025
Q3 		$29.3K Buy
+4,750
New +$27.8K ﹤0.01% 6390
2025
Q2 		– Sell
-3,768
Closed -$13.3K – 8598
2025
Q1 		$13.9K Sell
3,768
-1,656
-31% -$7.09K ﹤0.01% 6050
2024
Q4 		$21.7K Sell
5,424
-3,000
-36% -$16.5K ﹤0.01% 5633
2024
Q3 		$58.7K Buy
+8,424
New +$68.3K ﹤0.01% 4543
2023
Q4 		– Sell
-214
Closed -$684 – 8142
2023
Q3 		$539 Hold
214
– – ﹤0.01% 7329
2023
Q2 		$1.12K Sell
214
-60
-22% -$338 ﹤0.01% 7238
2023
Q1 		$1.3K Sell
274
-13
-5% -$78 ﹤0.01% 6723
2022
Q4 		$1.54K Sell
287
-823
-74% -$5.39K ﹤0.01% 6732
2022
Q3 		$8K Buy
1,110
+193
+21% +$1.95K ﹤0.01% 6648
2022
Q2 		$8K Buy
+917
New +$9.53K ﹤0.01% 6888
2021
Q4 		– Sell
-863
Closed -$26.4K – 8788
2021
Q3 		$31K Buy
+863
New +$36.6K ﹤0.01% 6903
2021
Q2 		– Sell
-1,653
Closed -$109K – 8538
2021
Q1 		$137K Buy
1,653
+340
+26% +$37.6K ﹤0.01% 5360
2020
Q4 		$149K Buy
+1,313
New +$83K ﹤0.01% 4286
2020
Q3 		– Sell
-1,237
Closed -$47.4K – 6509
2020
Q2 		$54K Sell
1,237
-2,506
-67% -$104K ﹤0.01% 4305
2020
Q1 		$134K Sell
3,743
-3,402
-48% -$168K ﹤0.01% 3063
2019
Q4 		$477K Buy
7,145
+4,087
+134% +$451K ﹤0.01% 2471
2019
Q3 		$474K Sell
3,058
-2,493
-45% -$282K ﹤0.01% 2380
2019
Q2 		$479K Buy
5,551
+4,090
+280% +$446K ﹤0.01% 2175
2019
Q1 		$202K Buy
1,461
+1,387
+1,874% +$348K ﹤0.01% 2699
2018
Q4 		$30K Buy
74
+67
+957% +$31.5K ﹤0.01% 3818
2018
Q3 		$5K Buy
+7
New +$4.4K ﹤0.01% 4853

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's SLDB Position: Q2 2026 in Review

Group One Trading opened a new position in Solid Biosciences (SLDB) in Q2 2026: 4,230 shares worth $42.3K. The stake represents ﹤0.01% of the portfolio and ranks #5502 among its holdings. This is a return to the name: Group One Trading previously reported a position in SLDB as recently as Q4 2025.

Group One Trading first reported a position in SLDB in Q3 2018 and has held it in 23 quarters since. The position peaked at $479K in Q2 2019. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Group One Trading held 4,230 shares of Solid Biosciences worth $42.3K as of Q2 2026.
  • Solid Biosciences was a new Group One Trading position in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5502 holding.
  • Group One Trading first reported a position in Solid Biosciences in Q3 2018 and has held it in 23 quarters since.
  • Group One Trading's Solid Biosciences position peaked at $479K in Q2 2019.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.